Delivery Order SPE2DB22D2009-SPE2DB25FM1JG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,158.11 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray (16 gm) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's extensive supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16 GM units. This non-competitive award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed-price delivery order under a larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency has awarded a delivery order valued at $1,730.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16-gram units. This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 16, 2025. The delivery order was awarded on September 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.61 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a direct fulfillment order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms spray (16-gram unit) valued at $1,396.90 under a firm fixed-price contract type. This delivery order, issued on August 19, 2025, represents a non-competitive set-aside and carries an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,611.24 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray (16 gm) on September 17, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Fluticasone Propionate 50 MCG Spray in 16GM units, with a ceiling value of $2,439.33. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion on September 9, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.88 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate 50 MCG Spray in 16GM units. This is a firm fixed-price, non-set-aside contract with a completion date of September 9, 2025, issued on September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,469.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Fluticasone Propionate 50 MCG Spray in 16GM units. The contract, which represents a non-competitive delivery order, is scheduled for ultimate completion by September 8, 2025. AmerisourceBergen Drug Corp will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1JGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract was awarded on a firm fixed price basis without any set-aside designation, indicating competitive award through open competition. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical products and medical supplies to support military healthcare systems worldwide. The parent IDC serves as a flexible vehicle enabling the company to fulfill diverse federal medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/5/25 |